NEOMED-LABS and Public Health England Partner for Global Health

Aims to build universal program to support prophylactic and therapeutic vaccine development from preclinical to post-licensure in various fields

NEOMED-LABS and Public Health England’s (PHE) National Infection Service have entered a strategic partnership aimed at improving global human health. This partnership is focused on vaccine projects with the objective of jointly developing new preclinical and clinical assays to support R&D and clinical biopharmaceutical teams in fields such as infectious disease vaccines and immunotherapies. NEOMED-LABS and PHE’s Vaccine Research Groups have engaged in a collaboration targeting Influenza ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters